PMV Pharmaceuticals (PMVP) Other financing activities (2021 - 2025)
PMV Pharmaceuticals' (PMVP) quarterly Other financing activities came in at $392000.0 in Q4 2025, up 127.91% YoY from $172000.0 in Q4 2024, and up 280.58% on a QoQ basis from $103000.0 in Q2 2025.
PMV Pharmaceuticals (PMVP) Other financing activities (2021 - 2025) Analysis & Trends
PMV Pharmaceuticals (PMVP) has 5 years of Other financing activities data on file, last reported at $392000.0 in Q4 2025.
- Quarterly Other financing activities rose 127.91% year-over-year to $392000.0 in Q4 2025, while the trailing twelve-month figure through Mar 2026 was $495000.0 (up 53.25% YoY) and the FY2025 annual result came in at $505000.0, up 61.34% from the prior year.
- Other financing activities improved to $392000.0 in Q4 2025, from $103000.0 in the prior quarter.
- In the past five years, Other financing activities ranged from a high of $1.3 million in Q2 2021 to a low of $6000.0 in Q3 2022.
- A 5-year average of $250235.3 and a median of $162000.0 in 2021 frame the typical range for Other financing activities.
- Annual changes were most pronounced in 2022 — Other financing activities tumbled 98.06% — and 2023, when it surged 750.0%.
- Tracing PMVP's Other financing activities over 5 years: stood at $295000.0 in 2021, then jumped by 85.76% to $548000.0 in 2022, then tumbled by 47.45% to $288000.0 in 2023, then sank by 40.28% to $172000.0 in 2024, then soared by 127.91% to $392000.0 in 2025.
- The last three Other financing activities figures came in at $392000.0 (Q4 2025), $103000.0 (Q2 2025), and $10000.0 (Q1 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | PMV Pharmaceuticals | 70.74 Mn | -8.69 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 392,000.00 |
| Dec 31, 2025 | 392,000.00 |
| Jun 30, 2025 | 103,000.00 |
| Jun 30, 2025 | 103,000.00 |
| Mar 31, 2025 | 10,000.00 |
| Mar 31, 2025 | 10,000.00 |
| Dec 31, 2024 | 172,000.00 |
| Dec 31, 2024 | 172,000.00 |
| Jun 30, 2024 | 141,000.00 |
| Jun 30, 2024 | 141,000.00 |
| Dec 31, 2023 | 288,000.00 |
| Dec 31, 2023 | 288,000.00 |
| Sep 30, 2023 | 51,000.00 |
| Sep 30, 2023 | 51,000.00 |
| Jun 30, 2023 | 105,000.00 |
| Jun 30, 2023 | 105,000.00 |
| Mar 31, 2023 | 12,000.00 |
| Mar 31, 2023 | 12,000.00 |
| Dec 31, 2022 | 548,000.00 |
| Dec 31, 2022 | 548,000.00 |